C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 61/100How is this calculated?

DEA Timing, Tilray Filings and What US Policy Means for MSOs

DEA post-hearing deadlines and Tilray’s fiscal filings recalibrate regulatory risk for US MSOs and ancillaries; watch 280E, state rollouts and capital access.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.